Wallen H - Search Results

1

An increased tendency in fibrinogen activity and its association with a hypo-fibrinolytic state in early stages after injury in patients without acute traumatic coagulopathy (ATC).

He S, Blombäck M, Boström F, Wallen H, Svensson J, Östlund A. He S, et al. Among authors: wallen h. J Thromb Thrombolysis. 2018 May;45(4):477-485. doi: 10.1007/s11239-018-1642-1. J Thromb Thrombolysis. 2018. PMID: 29564685 Free PMC article.

2

Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications.

Antovic JP, Yngen M, Ostenson CG, Antovic A, Wallen HN, Jorneskög G, Blombäck M. Antovic JP, et al. Blood Coagul Fibrinolysis. 2003 Sep;14(6):551-6. doi: 10.1097/00001721-200309000-00006. Blood Coagul Fibrinolysis. 2003. PMID: 12960608

3

Marked increase of fibrin gel permeability with very low dose ASA treatment.

Antovic A, Perneby C, Ekman GJ, Wallen HN, Hjemdahl P, Blombäck M, He S. Antovic A, et al. Thromb Res. 2005;116(6):509-17. doi: 10.1016/j.thromres.2005.02.007. Thromb Res. 2005. PMID: 16181986

4

Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.

Rooth E, Wallen H, Antovic A, von Arbin M, Kaponides G, Wahlgren N, Blombäck M, Antovic J. Rooth E, et al. Among authors: wallen h. Blood Coagul Fibrinolysis. 2007 Jun;18(4):365-70. doi: 10.1097/MBC.0b013e3281139c34. Blood Coagul Fibrinolysis. 2007. PMID: 17473579

5

A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma.

He S, Zhu K, Skeppholm M, Vedin J, Svensson J, Egberg N, Blombäck M, Wallen H. He S, et al. Among authors: wallen h. Thromb Haemost. 2007 Oct;98(4):871-82. Thromb Haemost. 2007. PMID: 17938814

6

Platelet dysfunction in patients with severe traumatic brain injury.

Nekludov M, Bellander BM, Blombäck M, Wallen HN. Nekludov M, et al. J Neurotrauma. 2007 Nov;24(11):1699-706. doi: 10.1089/neu.2007.0322. J Neurotrauma. 2007. PMID: 18001200

7

ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus.

Skeppholm M, Kallner A, Kalani M, Jörneskog G, Blombäck M, Wallén HN. Skeppholm M, et al. Blood Coagul Fibrinolysis. 2009 Dec;20(8):619-26. doi: 10.1097/MBC.0b013e32832da183. Blood Coagul Fibrinolysis. 2009. PMID: 19809308

8

Changes in von Willebrand factor and ADAMTS13 during IVF.

Westerlund E, Antovic A, Hovatta O, Eberg KP, Blombäck M, Wallén H, Henriksson P. Westerlund E, et al. Among authors: wallen h. Blood Coagul Fibrinolysis. 2011 Mar;22(2):127-31. doi: 10.1097/MBC.0b013e32834363ea. Blood Coagul Fibrinolysis. 2011. PMID: 21192251

9

Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate.

Blombäck M, He S, Bark N, Wallen HN, Elg M. Blombäck M, et al. Br J Haematol. 2011 Mar;152(6):758-65. doi: 10.1111/j.1365-2141.2010.08546.x. Epub 2011 Jan 20. Br J Haematol. 2011. PMID: 21250974 Free article.

10

Is fibrin formation and thrombin generation increased during and after an acute coronary syndrome?

Skeppholm M, Kallner A, Malmqvist K, Blombäck M, Wallén H. Skeppholm M, et al. Among authors: wallen h. Thromb Res. 2011 Nov;128(5):483-9. doi: 10.1016/j.thromres.2011.03.011. Epub 2011 Apr 14. Thromb Res. 2011. PMID: 21496882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters